TB Alliance and BioFocus sign compound management agreement
Advertisement
BioFocus announced that it has signed a three year compound management agreement with the Global Alliance for TB Drug Development (TB Alliance). Under this agreement BioFocus will manage TB Alliance’s chemical library collection. These services will be provided by BioFocus’ compound management facility in South San Francisco, USA.
Other news from the department business & finance
These products might interest you
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Amynon Biotech GmbH - Innsbruck, Austria
Cell Culture Technologies LLC - Gravesano, Switzerland
Georg Fischer DEKA GmbH - Mornshausen, Germany
Calixar and Synthelis team up to provide unique membrane protein services
Thai_Red_Cross_Society
Hemorrhagic Fevers: Countering Inflammation to Prevent Circulatory Failure
Danqi_Jiaonang
Merck Animal Health Facility Among the First Sites Certified According to New Standard CWA 15793:2008 on Laboratory Biorisk Management
Tracking Down False Parkers in Cancer Cells
inno-train Diagnostik GmbH - Kronberg, Germany